ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...

The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not ...

The trial's primary goal is to assess the efficacy, safety and tolerability of daily oral doses of SCI-110 in adults aged 18 ...

Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often encounters significant hurdles.

The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...

After a six-month beta testing period, the European Clinical Trials Information Network is rolling out its patient ...

Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, ...

Founded by renowned and experienced African biostatisticians, Optima Clinical aims to revolutionize data management and ...

Pioneering Study in Parkinson's Disease to Advance Surgical Treatment Options RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, today announced ...

FDA confirms that SciSparc’s study may proceedonly a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...

Mural Oncology a clinical-stage oncology company focused on discovering and developing immunotherapies, held its first ...

Cheong points to the broad spectrum of patient demographics in the APAC region for creating substantial opportunities for clinical trial sponsors who are keen to meet enrolment targets at an expedited ...